MyoKardia Company Profile (NASDAQ:MYOK)

About MyoKardia

MyoKardia logoMyoKardia, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that results from biomechanical defects in cardiac muscle contraction. It is engaged in the business of developing and commercializing therapeutics. Its pipeline includes over four therapeutic programs for the chronic treatment of over two forms of heritable cardiomyopathy-hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM). Its lead product candidate, MYK-461, is an orally-administered small molecule that reduces cardiac muscle contractility leading to HCM. In preclinical models of HCM, MYK-461 has been shown to prevent and reverse disease progression and to reduce left ventricular outflow tract obstruction. It is evaluating MYK-461 in over three Phase I clinical trials, including approximately two single ascending dose (SAD) trials and over one multiple ascending dose (MAD) trial.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MYOK
  • CUSIP:
Key Metrics:
  • Previous Close: $12.25
  • 50 Day Moving Average: $12.34
  • 200 Day Moving Average: $15.77
  • 52-Week Range: $6.87 - $22.83
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.31
  • P/E Growth: 0.00
  • Market Cap: $384.99M
  • Outstanding Shares: 31,428,000
  • Beta: 6.53
Profitability:
  • Net Margins: -248.75%
  • Return on Equity: -43.41%
  • Return on Assets: -35.87%
Debt:
  • Current Ratio: 6.38%
  • Quick Ratio: 6.38%
Additional Links:
Companies Related to MyoKardia:

Analyst Ratings

Consensus Ratings for MyoKardia (NASDAQ:MYOK) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.00 (104.92% upside)

Analysts' Ratings History for MyoKardia (NASDAQ:MYOK)
Show:
DateFirmActionRatingPrice TargetDetails
11/8/2016Cowen and CompanyReiterated RatingBuy$28.00View Rating Details
11/7/2016WedbushReiterated RatingOutperform$24.00View Rating Details
9/22/2016Wells Fargo & CompanyReiterated RatingBuyView Rating Details
7/20/2016BMO Capital MarketsInitiated CoverageOutperform$3.00 -> $28.00View Rating Details
7/12/2016Credit Suisse GroupReiterated RatingBuy$16.00 -> $20.00View Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for MyoKardia (NASDAQ:MYOK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/16/2017        
11/7/2016Q316($0.07)($0.35)$4.83 million$3.55 millionViewN/AView Earnings Details
8/9/2016Q216($0.33)($0.37)$3.55 million$3.55 millionViewN/AView Earnings Details
5/12/2016Q1($0.53)($0.32)ViewN/AView Earnings Details
3/18/2016Q4($0.68)($0.48)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MyoKardia (NASDAQ:MYOK)
Current Year EPS Consensus Estimate: $-1.50 EPS
Next Year EPS Consensus Estimate: $-1.67 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.34)($0.34)($0.34)
Q3 20161($0.34)($0.34)($0.34)
Q4 20161($0.31)($0.31)($0.31)
Q1 20171($0.18)($0.18)($0.18)
Q2 20171($0.20)($0.20)($0.20)
Q3 20171($0.21)($0.21)($0.21)
Q4 20171($0.22)($0.22)($0.22)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MyoKardia (NASDAQ:MYOK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MyoKardia (NASDAQ:MYOK)
Insider Ownership Percentage: 46.10%
Institutional Ownership Percentage: 45.43%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2016SanofiMajor ShareholderBuy450,000$15.00$6,750,000.00View SEC Filing  
11/3/2015Anastasios GianakakosCEOBuy1,350$10.00$13,500.00View SEC Filing  
11/3/2015Jonathan C FoxInsiderBuy3,000$10.00$30,000.00View SEC Filing  
11/3/2015Mark L PerryDirectorBuy5,000$10.00$50,000.00View SEC Filing  
11/3/2015SanofiMajor ShareholderBuy900,000$10.00$9,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MyoKardia (NASDAQ:MYOK)
DateHeadline
capitalcube.com logoMyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : February 17, 2017 (NASDAQ:MYOK)
www.capitalcube.com - February 17 at 4:57 PM
reuters.com logoBRIEF-Myokardia says first subjects dosed in cardiomyopathy drug study (NASDAQ:MYOK)
www.reuters.com - February 3 at 7:28 PM
finance.yahoo.com logoFirst Subjects Dosed in Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491 (NASDAQ:MYOK)
finance.yahoo.com - February 2 at 7:35 PM
streetinsider.com logoMyoKardia (MYOK) Appoints June Lee as COO (NASDAQ:MYOK)
www.streetinsider.com - February 2 at 12:47 AM
us.rd.yahoo.com logoMyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs (NASDAQ:MYOK)
us.rd.yahoo.com - February 1 at 7:47 PM
News IconMyoKardia Inc MYOK Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:MYOK)
www.bioportfolio.com - January 14 at 6:49 PM
reuters.com logoBRIEF-MyoKardia files for mixed shelf offering of up to $250 mln (NASDAQ:MYOK)
www.reuters.com - January 6 at 1:10 AM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (NASDAQ:MYOK)
us.rd.yahoo.com - January 5 at 3:11 AM
4-traders.com logoNPA -Class 4 Drug Alert: Caution in use - Arava film-coated tablets 10mg (NASDAQ:MYOK)
www.4-traders.com - January 4 at 7:31 PM
News IconDrug seems to treat deadly heart disease in cats (NASDAQ:MYOK)
www.futurity.org - January 4 at 7:31 PM
News IconCloud Logistics Continues Torrid Pace by Reporting Record Growth, Revenue and Innovation in 2016 (NASDAQ:MYOK)
www.econotimes.com - January 3 at 10:43 AM
reuters.com logoBRIEF-Myokardia says Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration (NASDAQ:MYOK)
www.reuters.com - January 3 at 10:43 AM
publicnow.com logoMyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi (NASDAQ:MYOK)
www.publicnow.com - January 3 at 10:43 AM
News IconNew Drug for Heart Disease Shows Promise for Cats and Humans (NASDAQ:MYOK)
www.ucdavis.edu - December 22 at 7:02 PM
capitalcube.com logoETFs with exposure to MyoKardia, Inc. : December 12, 2016 (NASDAQ:MYOK)
www.capitalcube.com - December 12 at 6:52 PM
insidermonkey.com logoIs Myokardia Inc (MYOK) A Good Stock To Buy? (NASDAQ:MYOK)
www.insidermonkey.com - December 9 at 9:01 AM
finance.yahoo.com logoMyoKardia to Present at 2016 BMO Capital Markets Healthcare Conference (NASDAQ:MYOK)
finance.yahoo.com - December 8 at 9:50 AM
reuters.com logoBRIEF-Myokardia says got $25 mln payment for deal with Myokardia,Sanofi (NASDAQ:MYOK)
www.reuters.com - December 3 at 11:07 AM
streetinsider.com logoMyoKardia (MYOK) Receives $25M Milestone Related to MYK-491 Development (SNY) (NASDAQ:MYOK)
www.streetinsider.com - December 3 at 11:07 AM
us.rd.yahoo.com logoMyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491 (NASDAQ:MYOK)
us.rd.yahoo.com - December 2 at 11:12 AM
capitalcube.com logoETFs with exposure to MyoKardia, Inc. : December 1, 2016 (NASDAQ:MYOK)
www.capitalcube.com - December 1 at 6:39 PM
capitalcube.com logoMyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : December 1, 2016 (NASDAQ:MYOK)
us.rd.yahoo.com - December 1 at 9:24 AM
us.rd.yahoo.com logoMyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer (NASDAQ:MYOK)
us.rd.yahoo.com - December 1 at 9:24 AM
us.rd.yahoo.com logo8:05 am MyoKardia appoints Marc Semigran, M.D., as chief medical officer (NASDAQ:MYOK)
us.rd.yahoo.com - December 1 at 9:24 AM
capitalcube.com logoMyoKardia, Inc. :MYOK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016 (NASDAQ:MYOK)
www.capitalcube.com - November 21 at 11:38 AM
finance.yahoo.com logoMYOKARDIA INC Financials (NASDAQ:MYOK)
finance.yahoo.com - November 16 at 6:40 PM
capitalcube.com logoETFs with exposure to MyoKardia, Inc. : November 15, 2016 (NASDAQ:MYOK)
www.capitalcube.com - November 15 at 6:57 PM
capitalcube.com logoMyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : November 14, 2016 (NASDAQ:MYOK)
www.capitalcube.com - November 14 at 10:27 AM
streetinsider.com logoMyoKardia (MYOK) Commences PIONEER-HCM Trial Substudy in oHCM Patients (NASDAQ:MYOK)
www.streetinsider.com - November 12 at 8:55 AM
nasdaq.com logoMyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in (NASDAQ:MYOK)
www.nasdaq.com - November 11 at 6:03 PM
publicnow.com logoMyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients (NASDAQ:MYOK)
www.publicnow.com - November 11 at 8:54 AM
fxpips.com logoTop 20 Earning Companies, NASDAQ, Pre-Market, Nov. 10 (NASDAQ:MYOK)
www.fxpips.com - November 10 at 9:21 AM
finance.yahoo.com logoMyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results (NASDAQ:MYOK)
finance.yahoo.com - November 7 at 6:56 PM
sg.finance.yahoo.com logoMyoKardia reports 3Q loss (NASDAQ:MYOK)
sg.finance.yahoo.com - November 7 at 10:08 AM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:MYOK)
biz.yahoo.com - November 7 at 10:08 AM
einnews.com logoCyber Security Market is projected to be the fastest-growing Market during the period 2016 to 2021 (NASDAQ:MYOK)
automotive.einnews.com - November 6 at 10:59 AM
News IconHD Supply Holdings Inc to Present at Robert W Baird 2016 Industrial Conference (NASDAQ:MYOK)
www.econotimes.com - November 4 at 5:47 PM
publicnow.com logoMyoKardia Announces Presentations at American Heart Association Scientific Sessions 2016 (NASDAQ:MYOK)
www.publicnow.com - November 4 at 9:48 AM
einnews.com logoRiskVision Named a Top 20 Cybersecurity Leader of 2016 in Risk Management by Cyber Defense Magazine (NASDAQ:MYOK)
semiconductors.einnews.com - November 3 at 10:15 AM
publicnow.com logoMyoKardia Announces Dosing of First Patient in Phase 2 PIONEER-HCM Study of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy (NASDAQ:MYOK)
www.publicnow.com - November 2 at 9:52 AM
News IconOpen-Data Movement: Share and Share Alike? (NASDAQ:MYOK)
www.medscape.com - October 31 at 6:23 PM
einnews.com logoPort Authority: 4 arrested after traffic stop with $11,000 in stolen goods (NASDAQ:MYOK)
uspolitics.einnews.com - October 31 at 12:58 PM
seekingalpha.com logoBiotech Snapshot: Myokardia Has A Heart Of Gold (NASDAQ:MYOK)
seekingalpha.com - October 31 at 12:58 PM
publicnow.com logoMyoKardia to Present at Two Upcoming Investor Conferences in November (NASDAQ:MYOK)
www.publicnow.com - October 31 at 12:58 PM
insidermonkey.com logoMyokardia Inc (MYOK): Cormorant Asset Management Raises Its Stake (NASDAQ:MYOK)
www.insidermonkey.com - October 14 at 6:06 PM
reuters.com logoBRIEF-Great Point Partners reports 7.57 pct passive stake in Foamix Pharma: SEC (NASDAQ:MYOK)
in.reuters.com - October 12 at 11:38 AM
reuters.com logoBRIEF-Cormorant Asset Management Llc reports 5.12 percent passive stake in Myokardia Inc (NASDAQ:MYOK)
www.reuters.com - October 11 at 6:34 PM
publicnow.com logoMyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares (NASDAQ:MYOK)
www.publicnow.com - October 3 at 5:56 PM
reuters.com logoBRIEF-Myokardia announces pricing of proposed public offering of common stock (NASDAQ:MYOK)
www.reuters.com - September 28 at 11:19 AM
streetinsider.com logoMyoKardia (MYOK) Prices 3.8M Shares Stock Offering for Proceeds of ~$57M (NASDAQ:MYOK)
www.streetinsider.com - September 28 at 11:19 AM

Social

What is MyoKardia's stock symbol?

MyoKardia trades on the NASDAQ under the ticker symbol "MYOK."

Where is MyoKardia's stock going? Where will MyoKardia's stock price be in 2017?

5 brokerages have issued 1 year price targets for MyoKardia's stock. Their predictions range from $20.00 to $28.00. On average, they expect MyoKardia's share price to reach $25.00 in the next twelve months.

When will MyoKardia announce their earnings?

MyoKardia is scheduled to release their next quarterly earnings announcement on Thursday, March, 16th 2017.

Who owns MyoKardia stock?

MyoKardia's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include FMR LLC (12.38%), Perceptive Advisors LLC (1.99%), Deerfield Management Co. (1.35%), State Street Corp (0.57%), Marshall Wace LLP (0.39%) and Harbourvest Partners LLC (0.14%). Company insiders that own MyoKardia stock include Anastasios Gianakakos, Jonathan C Fox, Mark L Perry and Sanofi.

Who sold MyoKardia stock? Who is selling MyoKardia stock?

MyoKardia's stock was sold by a variety of institutional investors in the last quarter, including Deerfield Management Co..

Who bought MyoKardia stock? Who is buying MyoKardia stock?

MyoKardia's stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Harbourvest Partners LLC, State Street Corp, Marshall Wace LLP, Trexquant Investment LP, A.R.T. Advisors LLC, Aberdeen Asset Management PLC UK and Bessemer Group Inc.. Company insiders that have bought MyoKardia stock in the last two years include Anastasios Gianakakos, Jonathan C Fox, Mark L Perry and Sanofi.

How do I buy MyoKardia stock?

Shares of MyoKardia can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of MyoKardia stock cost?

One share of MyoKardia stock can currently be purchased for approximately $12.20.

MyoKardia (NASDAQ:MYOK) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for MyoKardia (NASDAQ:MYOK)

Earnings History Chart

Earnings by Quarter for MyoKardia (NASDAQ:MYOK)

Dividend History Chart

Dividend Payments by Quarter for MyoKardia (NASDAQ:MYOK)

Last Updated on 2/24/2017 by MarketBeat.com Staff